Recursion Pharmaceuticals (RXRX) Share-based Compensation Growth (3y) (2023 - 2026)
Recursion Pharmaceuticals (RXRX) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 4.80% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 10.78% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | 36.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.09% |
| Dec 31, 2025 | 45.62% |
| Sep 30, 2025 | 41.52% |
| Jun 30, 2025 | 66.42% |
| Mar 31, 2025 | 85.69% |
| Dec 31, 2024 | 92.12% |
| Sep 30, 2024 | 75.74% |
| Jun 30, 2024 | 45.93% |
| Mar 31, 2024 | 106.89% |
| Dec 31, 2023 | 138.35% |
| Sep 30, 2023 | 150.36% |
| Jun 30, 2023 | 148.57% |
| Mar 31, 2023 | 91.00% |